
Basic Protective Measures Against COVID-19
COVID-19 is a new strain of the common cold that has been p...
COVID-19 is a new strain of the common cold that has been p...
Cladribine is used for the treatment of hairy cell leukemia and lymphocytic leukemia. Hairy cell leukemia is a slow-growing cancer of the blood in which your bone marrow makes too many B cells. The excess B cells are abnormal and look hairy under a microscope. Lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes. It is a blood and bone marrow disease.
Cladribine works by stopping the abnormal blood cells from multiplying. It does this by inhibiting the production of the cell’s genetic material, RNA, and DNA. Both RNA and DNA are needed for the growth and multiplication of cells. Cladribine causes a deficiency of RNA and DNA in cancerous cells. It causes them to grow in an unbalanced way resulting in the death of the cells.
This medication is given by injection into a vein by your doctor. The dosage is based on your medical condition, age, weight, and response. Cladribine is usually given continuously for 7 days in a row or as directed by your doctor for hairy cell leukemia. For the treatment of Lymphocytic leukemia, this is given every day for the first five days of a 28 days cycle.
Clean the injection site first with rubbing alcohol. To lessen the injury, change the injection site each time. It is important that you take this medication exactly as it is prescribed. Remember to use this at the same time every day or as directed by your doctor.